Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Syntec Optics Holdings Inc.
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results
Business
Oct 6 2025
21 min read

Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results

news images

Adjusted EBITDA Grew to 15.3% in the First Half of 2025 Compared to 7.7% in Full-Year 2024, First Half 2025 Earnings per Share Rises to $0.00 from Negative $0.03 in 2024

ROCHESTER, NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment & scientific instruments manufacturers, reported financial and operational results for the full year 2024 and first half 2025.

Full Year 2024 Financial Highlights

  • Sales from products increase by $1.9 million year-over-year

  • Adjusted EBITDA of $2.2 million was positive but down $3.1 million from the 2023 adjusted EBITDA of $5.3 million

  • Cash, including available lines of credit, was nearly $5.1 million

First Half 2025 Financial Highlights

  • Net Sales of $13.6 million, up $0.3 million from $13.3 million compared to 2024

  • Adjusted EBITDA as a percentage of revenue increased to 15.3% for the six months ended June 30, 2025, compared to 5.8% for the same period in 2024

  • Cash, including available lines of credit, was $4.3 million

  • 8% of principal on commercial bank lines was paid down during the six months ended June 30, 2025

  • Net income for the six-month period ending June 30, 2025, improved by $0.9 million versus the same period in 2024

Operational and Business Highlights

  • Entered a new end-market - Energy - by enabling light for space-based solar power and grid-scale fusion energy products in the first half of 2025

  • Strengthened the management team in the first part of 2025 for public markets

  • Continued production on night vision goggles, integrated scope, and other aiming scope optics for defense in 2024 and the first half of 2025

  • Continued production for disposable optics for biomedical diagnostics in 2024 and the first half of 2025

  • Continued production for Low Earth Orbit Satellite Space Optics in 2024 and the first half of 2025

  • Launched one new product in optical connectivity for Artificial Intelligence deployment-based scaling of data centers in 2024, and started production runs in the first half of 2025

  • Initiated engineering that expands the space optics line of products into new products for complementary ground networks and satellite path tracking

The calendar year 2024 was marked by record-high Net Sales and growth within the new end-market – Communications, a double-digit increase. This includes sales for Space Optics and AI-driven Data Center optical connectivity.

Syntec Optics leveraged a robust platform and continued to innovate, offering products for existing markets and utilizing existing capabilities to serve existing customers. Space Optics reached higher production levels. Next, low-weight hybrid optics used in night vision goggle systems are finalizing volume production OEM acceptances. Production ramp occurs after the product is produced on a higher volume line, meets customer specifications, and is integrated into the end product by the customer for final OEM acceptance.

Full Year 2024 Financial and Operating Results

Sales from products increase by $1.9 million year-over-year in the Net Sales of $28.4 million, reflecting strong gains in capacity utilization and robust product demand while moving from pilot plant to mass production on several major product lines.

Adjusted EBITDA of $2.2 million decreased from the 2023 adjusted EBITDA of $5.3 million, primarily driven by the decrease in net income resulting from the costs associated with the company’s transition and reorganizing for public markets, which the company believes can be reduced in the years to follow.

Specifically for the fourth quarter, we provided guidance at our last call that fourth-quarter revenue would exceed $7.4 million. Our actual revenue for the quarter was $7.3 million.

We are pleased to announce that in 2024, we invested $3.3 million in state-of-the-art equipment to enhance our capacity to reliably service our customers. These investments will enable us to continue developing our key technologies for our customers in 2025 and beyond. 

First Half 2025 Financial and Operating Results

Sales for the six months ended June 30, 2025, totaled $13.6 million, an increase of $0.3 million from the same period in 2024. This growth was driven by increases in biomedical industry sales of $0.8 million and defense tech industry sales of $0.6 million.

Gross profit for the six months was $3.9 million, a $1.0 million improvement over 2024’s $2.9 million gross profit, moving our gross margin from 22% for the six months ending June 30, 2024, up to 29% for the six months ending June 30, 2025.  Improvements across materials, labor, and manufacturing overhead all contributed to the improvements as the Company drives towards greater efficiencies. The company believes it will continue to improve gross profits as yields improve.

General and administrative expenses for the six months ending June 30, 2025, were $3.5M, a $0.6 million reduction from 2024. There were reductions of $0.4 million in outside consulting, $0.1 million in travel.

Adjusted EBITDA of $2.1 million increased by $1.2 million from the first half of the prior year, resulting in our adjusted EBITDA as a percentage of revenue rising from 5.8% in 2024 in the same period to 15.3% for the six months ended June 30, 2025, representing a significant improvement in profitability.

The Company ended the second quarter of 2025 with unused lines of credit totaling $1.5 million and $2.8 million, as well as a paydown of 8% principal on other commercial bank lines for the six months ended June 30, 2025.

Net income for the six-month period ending June 30, 2025, of $0 million was an improvement of $0.9 million versus the same period in 2024, reflecting a $1.0 million improvement in gross profit and a $0.6 million reduction in general and administrative expenses, partially offset by increased interest and other expenses.   

Future Growth

Syntec Optics’ strategy is to lead the large yet often overlooked market for light-enabled products by offering a diverse product portfolio tailored to the needs of blue-chip customers. This approach leverages our operational strengths, including the horizontal and vertical integration of optics manufacturing processes and techniques. We believe that, as more products become light-enabled, we will continue to have growth opportunities for many years to come. Here is how we are currently executing on our strategy.

We have implemented a clear, three-pronged execution plan that provides a roadmap for sustainable growth and involves everyone in the company, including technicians who design and manufacture the intricate optics. By focusing first on operational excellence, then scaling our talented team, and finally expanding into new, high-growth, light-enabled markets, we are positioning Syntec Optics to capitalize on the immense opportunities.

The Company’s execution plan is centered on the following three pillars:

1.   Operational Excellence to Maximize Capacity: The first prong focuses on improving yield and maximizing capacity utilization to meet robust demand for our current products. All key customers are demanding increased volumes, in most cases, 20%, 50% to 100% higher than we are currently delivering. The Company is deploying enhanced operations KPIs, daily technician meetings (DTMs), and ERP dashboards to provide real-time data for decision-making. This initiative targets increased efficiency in key growth areas: LEO Satellite Optics (Communication), Aiming / Night Vision / Integrated Scopes Optics (Defense), Artificial Intelligence-driven Data Center Optics (Communication), and Hospital Diagnostic Optics (Biomedical). This execution builds upon our highly defensible model of vertical and horizontal integration.
2.   Scaling Production with Increased Staffing: Second, simultaneously targeted yield improvements from 40%-50% in some cases to 95%, Syntec is increasing staffing on night shifts. This will allow the Company to continue scaling its production platforms, ensuring it can not only satisfy existing customer demand but also prepare for the next wave of growth from new and emerging applications.
3.   Expansion into New Breakthrough Applications: The third prong centers on innovation and market expansion. As more products across end-markets become light-enabled, Syntec is securing new customers in breakthrough applications. Key new areas of delivering products include Fusion Energy (a new end-market), Hyperspectral Imaging (Defense), Ground Network for Satellite Communications (Space), and furthering Quantum Computing / DNA Sequencing, all simultaneously positioning the Company at the forefront of next-generation technology.

Syntec intends to codify this execution plan so that it can be applied to future inorganic growth through acquisitions.

About Syntec Optics

Syntec Optics Holdings, Inc. (Nasdaq: OPTX), headquartered in Rochester, NY, is one of the largest custom and diverse end-market optics and photonics manufacturers in the United States. Operating for over two decades, Syntec Optics runs a state-of-the-art facility with extensive core capabilities of various optics manufacturing processes, both horizontally and vertically integrated, to provide a competitive advantage for mission-critical OEMs. As more products become light-enabled, Syntec Optics continues to add more product lines, including recent Low Earth Orbit (LEO) satellite optics for communication, lightweight night vision goggle optics for defense, biomedical optics for defense, and data center optics for Artificial Intelligence. To learn more, visit www.syntecoptics.com.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, including certain financial forecasts and projections. All statements other than statements of historical fact contained in this press release, including statements as to the transactions contemplated by the business combination and related agreements, future results of operations and financial position, revenue and other metrics, planned products and services, business strategy and plans, objectives of management for future operations of Syntec Optics, market size, and growth opportunities, competitive position and technological and market trends, are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors (some of which are beyond the control of Syntec Optics), which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by Syntec Optics and its management, as the case may be, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to: 1) risk outlined in any prior SEC filings; 2) ability of Syntec Optics to successfully increase market penetration into its target markets; 3) the addressable markets that Syntec Optics intends to target do not grow as expected; 4) the loss of any key executives; 5) the loss of any relationships with key suppliers including suppliers abroad; 6) the loss of any relationships with key customers; 7) the inability to protect Syntec Optics’ patents and other intellectual property; 8) the failure to successfully execute manufacturing of announced products in a timely manner or at all, or to scale to mass production; 9) costs related to any further business combination; 10) changes in applicable laws or regulations; 11) the possibility that Syntec Optics may be adversely affected by other economic, business and/or competitive factors; 12) Syntec Optics’ estimates of its growth and projected financial results for the future and meeting or satisfying the underlying assumptions with respect thereto; 13) the impact of any pandemic, including any mutations or variants thereof and the Russian/Ukrainian or Israeli conflict, and any resulting effect on business and financial conditions; 14) inability to complete any investments or borrowings in connection with any organic or inorganic growth; 15) the potential for events or circumstances that result in Syntec Optics’ failure to timely achieve the anticipated benefits of Syntec Optics’ customer arrangements; and 16) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in prior SEC filings including registration statement on Form S-4 filed with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Syntec Optics does not give any assurance that Syntec Optics will achieve its expected results. Syntec Optics does not undertake any duty to update these forward-looking statements except as otherwise required by law.

For further information, please contact:

Investor Relations
InvestorRelations@syntecoptics.com
SOURCE: Syntec Optics Holdings, Inc. (Nasdaq: OPTX)




SYNTEC OPTICS HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2024 AND 2023

 

 

2024

 

 

2023

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash

 

$

598,787

 

 

$

2,158,245

 

Accounts Receivable, Net

 

 

5,739,205

 

 

 

6,800,064

 

Inventory

 

 

6,953,278

 

 

 

5,834,109

 

Prepaid Expenses and Other Assets

 

 

596,589

 

 

 

359,443

 

Income Tax Receivable

 

 

9,794

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total Current Assets

 

 

13,897,653

 

 

 

15,151,861

 

 

 

 

 

 

 

 

 

 

Property and Equipment, Net

 

 

11,668,859

 

 

 

11,101,052

 

 

 

 

 

 

 

 

 

 

Intangible Assets, Net

 

 

-

 

 

 

295,000

 

Deferred Tax Asset

 

 

439,942

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

26,006,454

 

 

$

26,547,913

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts Payable

 

$

2,706,392

 

 

$

3,042,315

 

Accrued Expenses

 

 

814,600

 

 

 

1,071,256

 

Federal Income Tax Payable

 

 

-

 

 

 

370,206

 

Deferred Revenue

 

 

36,512

 

 

 

-

 

Line of Credit

 

 

6,263,863

 

 

 

6,537,592

 

Current Maturities of Debt Obligations

 

 

467,742

 

 

 

362,972

 

Current Maturities of Finance Lease Obligations

 

 

284,002

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total Current Liabilities

 

 

10,573,111

 

 

 

11,384,341

 

 

 

 

 

 

 

 

 

 

Long-Term Liabilities

 

 

 

 

 

 

 

 

Long-Term Debt Obligations

 

 

2,614,812

 

 

 

2,024,939

 

Long-Term Finance Lease Obligations

 

 

1,784,449

 

 

 

-

 

Deferred Income Tax

 

 

-

 

 

 

74,890

 

 

 

 

 

 

 

 

 

 

Total Long-Term Liabilities

 

 

4,399,261

 

 

 

2,099,829

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

14,972,372

 

 

 

13,484,170

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Stockholder’s Equity

 

 

 

 

 

 

 

 

CL A Common Stock, Par value $.0001 per share; 121,000,000 authorized; 36,688,266 issued and outstanding as of December 31, 2024; 36,688,266 issued and outstanding as of December 31, 2023

 

 

3,669

 

 

 

3,669

 

Common Stock Value

 

 

3,669

 

 

 

3,669

 

Additional Paid-In Capital

 

 

2,377,204

 

 

 

1,927,204

 

Retained Earnings

 

 

8,653,209

 

 

 

11,132,870

 

 

 

 

 

 

 

 

 

 

Total Stockholder’s Equity

 

 

11,034,082

 

 

 

13,063,743

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholder’s Equity

 

$

26,006,454

 

 

$

26,547,913

 


SYNTEC OPTICS HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

Net Sales

 

$

28,449,941

 

 

$

29,441,180

 

 

 

 

 

 

 

 

 

 

Cost of Goods Sold

 

 

22,747,615

 

 

 

21,520,189

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

5,702,326

 

 

 

7,920,991

 

 

 

 

 

 

 

 

 

 

General and Administrative Expenses

 

 

8,278,720

 

 

 

6,379,879

 

 

 

 

 

 

 

 

 

 

Income (Loss) from Operations

 

 

(2,576,394

)

 

 

1,541,112

 

 

 

 

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

 

 

 

 

Other Income

 

 

346,835

 

 

 

370,914

 

Interest Expense, Including Amortization of Debt Issuance Costs

 

 

(764,934

)

 

 

(654,765

)

Total Other (Expense)

 

 

(418,099

)

 

 

(283,851

)

 

 

 

 

 

 

 

 

 

(Loss) Income Before Provision for (Benefit) Income Taxes

 

 

(2,994,493

)

 

 

1,257,261

 

 

 

 

 

 

 

 

 

 

Provision (Benefit) for Income Taxes

 

 

(514,832

)

 

 

(719,172

)

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$

(2,479,661

)

 

$

1,976,433

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) per Common Share

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.07

)

 

$

0.06

 

 

 

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding

 

 

 

 

 

 

 

 

Basic and diluted

 

 

36,688,266

 

 

 

32,366,725

 


SYNTEC OPTICS HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

 

 

2024

 

 

2023

 

Cash Flows From Operating Activities

 

 

 

 

 

 

 

 

Net (Loss) Income

 

$

(2,479,661

)

 

$

1,976,433

 

Adjustments to Reconcile (Loss) Income to Net Cash (Used In)

 

 

 

 

 

 

 

 

Provided By Operating Activities:

 

 

 

 

 

 

 

 

Adjustments to Reconcile (Loss) Income to Net Cash (Used In) Provided By Operating Activities:

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

2,765,713

 

 

 

2,769,284

 

Amortization of Debt Issuance Costs

 

 

15,057

 

 

 

12,451

 

Stock-Based Compensation

 

 

450,000

 

 

 

-

 

Grant Revenue Income

 

 

-

 

 

 

(300,000

)

Gain on Disposal of Property and Equipment

 

 

(309,000

)

 

 

-

 

Change in Allowance for Expected Credit Losses

 

 

(121,767

)

 

 

(25,820

)

Change in Reserve for Obsolescence

 

 

186,285

 

 

 

124,911

 

Deferred Income Taxes

 

 

(514,832

)

 

 

(1,199,214

)

(Increase) Decrease in:

 

 

 

 

 

 

 

 

Accounts Receivable

 

 

1,182,626

 

 

 

(848,520

)

Inventory

 

 

(1,305,454

)

 

 

(2,332,660

)

Prepaid Expenses and Other Assets

 

 

(237,146

)

 

 

340,298

 

Increase (Decrease) in:

 

 

 

 

 

 

 

 

Accounts Payables and Accrued Expenses

 

 

(231,163

)

 

 

2,493,826

 

Federal Income Tax Payable

 

 

(380,000

)

 

 

129,328

 

Deferred Revenue

 

 

36,512

 

 

 

(348,095

)

Net Cash (Used In) Provided By Operating Activities

 

 

(942,830

)

 

 

2,792,222

 

 

 

 

 

 

 

 

 

 

Cash Flows From Investing Activities

 

 

 

 

 

 

 

 

Purchases of Property and Equipment

 

 

(1,239,866

)

 

 

(1,921,181

)

Proceeds from Disposal of Property and Equipment

 

 

309,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Cash Used in Investing Activities

 

 

(930,866

)

 

 

(1,921,181

)

 

 

 

 

 

 

 

 

 

Cash Flows From Financing Activities

 

 

 

 

 

 

 

 

(Repayments) Borrowing on Line of Credit, Net

 

 

(273,729

)

 

 

137,592

 

Borrowing on Debt Obligations

 

 

1,100,388

 

 

 

1,745,573

 

Repayments on Debt Obligations

 

 

(420,802

)

 

 

(2,908,502

)

Repayments on Finance Lease Obligations

 

 

(91,619

)

 

 

-

 

Cash proceeds from OLIT

 

 

-

 

 

 

45,946

 

Net proceeds from OLIT Trust

 

 

-

 

 

 

1,802,479

 

Distributions

 

 

-

 

 

 

(62,065

)

 

 

 

 

 

 

 

 

 

Net Cash Provided By Financing Activities

 

 

314,238

 

 

 

761,023

 

 

 

 

 

 

 

 

 

 

Net Decrease in Cash

 

 

(1,559,458

)

 

 

1,632,064

 

 

 

 

 

 

 

 

 

 

Cash - Beginning

 

 

2,158,245

 

 

 

526,182

 

 

 

 

 

 

 

 

 

 

Cash - Ending

 

$

598,787

 

 

$

2,158,245

 

 

 

 

 

 

 

 

 

 

Supplemental Cash Flow Disclosures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Paid for Interest

 

$

738,010

 

 

$

652,778

 

 

 

 

 

 

 

 

 

 

Cash Paid for Taxes

 

$

568,143

 

 

$

283,561

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures of Non-Cash Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets Acquired and Included in Accounts Payable and Accrued Expenses

 

$

198,584

 

 

$

642,547

 

Issuance of finance lease for acquisition of equipment

 

$

2,160,070

 

 

$

-

 

De-recognition of PPE and Intangible Asset transaction

 

$

560,000

 

 

$

-

 


NON-GAAP RECONCILIATION OF EBITDA
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

 

 

2024

 

 

2023

 

Net (Loss) Income

 

$

(2,479,661

)

 

$

1,976,433

 

Stock-Based Compensation expense

 

 

450,000

 

 

 

-

 

Depreciation & Amortization

 

 

2,765,713

 

 

 

2,769,284

 

Amortization of Debt Issuance Costs

 

 

9,222

 

 

 

12,451

 

Interest Expenses

 

 

738,010

 

 

 

642,314

 

Taxes

 

 

(514,832

)

 

 

(719,172

)

Non-Recurring Items

 

 

 

 

 

 

 

 

Anomalous Executive Transition expenses

 

 

379,389

 

 

 

-

 

Nonrecurring professional Fees

 

 

174,500

 

 

 

-

 

Technology Start-up Costs

 

 

344,496

 

 

 

-

 

Optical Molding Evaluation Expenses

 

 

201,908

 

 

 

-

 

Glass Molding Evaluation Expenses

 

 

130,196

 

 

 

-

 

Sale of Equipment & Accessories

 

 

-

 

 

 

(10,068

)

Transaction Filing Fees

 

 

-

 

 

 

344,752

 

Management Fees & Expenses

 

 

-

 

 

 

318,334

 

Adjusted EBITDA

 

$

2,198,941

 

 

$

5,334,328

 


SYNTEC OPTICS HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
JUNE 30, 2025 AND DECEMBER 31, 2024

 

 

2025
(unaudited)

 

 

2024

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash

 

$

287,085

 

 

$

598,787

 

Accounts Receivable, Net

 

 

6,038,305

 

 

 

5,739,205

 

Inventory

 

 

7,992,617

 

 

 

6,953,278

 

Income Tax Receivable

 

 

-

 

 

 

9,794

 

Prepaid Expenses and Other Assets

 

 

321,301

 

 

 

596,589

 

 

 

 

 

 

 

 

 

 

Total Current Assets

 

 

14,639,308

 

 

 

13,897,653

 

 

 

 

 

 

 

 

 

 

Property and Equipment, Net

 

 

10,385,435

 

 

 

11,668,859

 

Deferred Tax Asset

 

 

270,360

 

 

 

439,942

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

25,295,103

 

 

$

26,006,454

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts Payable

 

$

1,854,077

 

 

$

2,706,392

 

Accrued Expenses

 

 

821,676

 

 

 

814,600

 

Deferred Revenue

 

 

33,993

 

 

 

36,512

 

Line of Credit

 

 

6,763,863

 

 

 

6,263,863

 

Current Maturities of Debt Obligations

 

 

482,973

 

 

 

467,742

 

Current Maturities of Finance Lease Obligations

 

 

340,492

 

 

 

284,002

 

 

 

 

 

 

 

 

 

 

Total Current Liabilities

 

 

10,297,074

 

 

 

10,573,111

 

 

 

 

 

 

 

 

 

 

Long-Term Liabilities

 

 

 

 

 

 

 

 

Long-Term Debt Obligations

 

 

2,372,985

 

 

 

2,614,812

 

Long-Term Finance Lease Obligations

 

 

1,611,218

 

 

 

1,784,449

 

 

 

 

 

 

 

 

 

 

Total Long-Term Liabilities

 

 

3,984,203

 

 

 

4,399,261

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

14,281,277

 

 

 

14,972,372

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

CL A Common Stock, Par value $.0001 per share; 121,000,000 authorized; 36,920,226 issued and outstanding as of June 30, 2025; 36,688,266 issued and outstanding as of December 31, 2024;

 

 

3,692

 

 

 

3,669

 

Common stock value

 

 

3,692

 

 

 

3,669

 

Additional Paid-In Capital

 

 

2,377,181

 

 

 

2,377,204

 

Retained Earnings

 

 

8,632,953

 

 

 

8,653,209

 

 

 

 

 

 

 

 

 

 

Total Stockholders’ Equity

 

 

11,013,826

 

 

 

11,034,082

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity

 

 

25,295,103

 

 

 

26,006,454

 


SYNTEC OPTICS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025 AND 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2025

 

 

June 30, 2024

 

 

June 30, 2025

 

 

June 30, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

 

$

6,559,455

 

 

$

7,006,000

 

 

$

13,628,497

 

 

$

13,261,908

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Goods Sold

 

 

4,961,489

 

 

 

4,831,673

 

 

 

9,721,913

 

 

 

10,380,138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

1,597,966

 

 

 

2,174,327

 

 

 

3,906,584

 

 

 

2,881,770

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and Administrative Expenses

 

 

1,744,216

 

 

 

2,015,783

 

 

 

3,524,382

 

 

 

4,130,326

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) from Operations

 

 

(146,250

)

 

 

158,544

 

 

 

382,202

 

 

 

(1,248,556

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Expense, Including Amortization of Debt Issuance Costs

 

 

(208,969

)

 

 

(167,242

)

 

 

(409,865

)

 

 

(327,109

)

Other Income

 

 

11,298

 

 

 

319,623

 

 

 

16,995

 

 

 

338,972

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other (Expense)

 

 

(197,671

)

 

 

152,381

 

 

 

(392,870

)

 

 

11,863

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) Before Provision for (Benefit) Income Taxes

 

 

(343,921

)

 

 

310,925

 

 

 

(10,668

)

 

 

(1,236,693

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision (Benefit) for Income Taxes

 

 

-

 

 

 

29,082

 

 

 

9,588

 

 

 

(309,393

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (Loss) Income

 

$

(343,921

)

 

$

281,843

 

 

$

(20,256

)

 

$

(927,300

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) per Common Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.01

)

 

$

0.01

 

 

$

(0.00

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

36,920,226

 

 

 

36,688,266

 

 

 

36,920,226

 

 

 

36,688,266

 


SYNTEC OPTICS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024

 

 

2025

 

 

2024

 

Cash Flows From Operating Activities

 

 

 

 

 

 

 

 

Net Loss

 

$

(20,256

)

 

$

(927,300

)

Adjustments to Reconcile Loss to Net Cash (Used In)

 

 

 

 

 

 

 

 

Provided By Operating Activities:

 

 

 

 

 

 

 

 

Adjustments to Reconcile (Loss) Income to Net Cash (Used In) Provided By Operating Activities:

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

1,387,427

 

 

 

1,385,606

 

Amortization of Debt Issuance Costs

 

 

4,834

 

 

 

4,387

 

Gain on Disposal of Property and Equipment

 

 

-

 

 

 

(309,000

)

Change in Allowance for Expected Credit Losses

 

 

75,727

 

 

 

(24,395

)

Change in Reserve for Obsolescence

 

 

(18,881

)

 

 

291,576

 

Deferred Income Taxes

 

 

-

 

 

 

(357,994

)

(Increase) Decrease in:

 

 

 

 

 

 

 

 

Accounts Receivable

 

 

(374,827

)

 

 

885,368

 

Inventory

 

 

(1,020,458

)

 

 

(1,958,557

)

Decrease in Federal Income Tax Receivable

 

 

179,376

 

 

 

-

 

Prepaid Expenses and Other Assets

 

 

275,288

 

 

 

57,309

 

Increase (Decrease) in:

 

 

 

 

 

 

 

 

Accounts Payables and Accrued Expenses

 

 

(344,470

)

 

 

(993,406

)

Federal Income Tax Payable

 

 

-

 

 

 

(318,240

)

Deferred Revenue

 

 

(2,519

)

 

 

280,763

 

 

 

 

 

 

 

 

 

 

Net Cash Provided By (Used In) Operating Activities

 

 

141,241

 

 

 

(1,983,883

)

 

 

 

 

 

 

 

 

 

Cash Flows From Investing Activities

 

 

 

 

 

 

 

 

Purchases of Property and Equipment

 

 

(604,772

)

 

 

(254,767

)

Proceeds from Disposal of Property and Equipment

 

 

-

 

 

 

309,000

 

 

 

 

 

 

 

 

 

 

Net Cash (Used in) Provided in Investing Activities

 

 

(604,772

)

 

 

54,233

 

 

 

 

 

 

 

 

 

 

Cash Flows From Financing Activities

 

 

 

 

 

 

 

 

(Repayments) Borrowing on Line of Credit, Net

 

 

500,000

 

 

 

(273,729

)

Borrowing on Debt Obligations

 

 

-

 

 

 

1,100,388

 

Repayments on Debt Obligations

 

 

(231,430

)

 

 

(224,775

)

Repayments on Finance Lease Obligations

 

 

(116,741

)

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Cash Provided By Financing Activities

 

 

151,829

 

 

 

601,884

 

 

 

 

 

 

 

 

 

 

Net Decrease in Cash

 

 

(311,702

)

 

 

(1,327,766

)

 

 

 

 

 

 

 

 

 

Cash - Beginning

 

 

598,787

 

 

 

2,158,245

 

 

 

 

 

 

 

 

 

 

Cash - Ending

 

$

287,085

 

 

$

830,479

 

 

 

 

 

 

 

 

 

 

Supplemental Cash Flow Disclosures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Paid for Interest

 

$

409,579

 

 

$

276,809

 

 

 

 

 

 

 

 

 

 

Cash Paid for Taxes

 

$

-

 

 

$

537,510

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures of Non-Cash Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets Acquired and Included in Accounts Payable and Accrued Expenses

 

$

40,362

 

 

$

651,736

 

 

 

 

 

 

 

 

 

 

Issuance of restricted stock from stock-based compensation

 

$

23

 

 

$

-

 


NON-GAAP RECONCILIATION OF EBITDA
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025 AND 2024

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2025

 

 

June 30, 2024

 

 

June 30, 2025

 

 

June 30, 2024

 

Net (Loss) Income

 

$

(343,921

)

 

$

281,843

 

 

$

(20,256

)

 

$

(927,300

)

Depreciation & Amortization

 

 

676,623

 

 

 

692,194

 

 

 

1,387,427

 

 

 

1,389,993

 

Debt Issuance Costs

 

 

2,418

 

 

 

-

 

 

 

4,834

 

 

 

-

 

Interest Expenses

 

 

207,623

 

 

 

164,828

 

 

 

409,579

 

 

 

322,722

 

Taxes

 

 

-

 

 

 

29,082

 

 

 

9,588

 

 

 

(309,393

)

Non-Recurring Items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executive Transition

 

 

135,246

 

 

 

-

 

 

 

249,189

 

 

 

-

 

One time Contract exit costs

 

 

11,750

 

 

 

-

 

 

 

21,063

 

 

 

-

 

Non-recurring property damage

 

 

-

 

 

 

-

 

 

 

21,261

 

 

 

-

 

Professional & Transaction Fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25,265

 

Technology Start-up Costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

165,034

 

Optical Molding Evaluation Expenses

 

  

-

 

 

 

-

 

 

 

-

 

 

 

38,104

 

Glass Molding Evaluation Expenses

 

 

-

 

 

 

-

 

 

 

-

 

 

 

68,392

 

Adjusted EBITDA

 

$

689,739

 

 

$

1,167,947

 

 

$

2,082,685

 

 

$

772,817